BMS-986454
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BMS-986454, covering 2025-03-24 to 2026-04-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis [Phase 1]